Quantcast
Channel: All News Releases
Viewing all articles
Browse latest Browse all 4794

Demystifying a Key Receptor in Substance Use and Neuropsychiatric Disorders; Study sheds light on TAAR1, pointing to potential drug development opportunities

$
0
0

Researchers at the Icahn School of Medicine at Mount Sinai have uncovered insights into the potential mechanism of action of the antipsychotic medication asenapine, a possible therapeutic target for substance use and neuropsychiatric disorders. This discovery may pave the way for the...


Viewing all articles
Browse latest Browse all 4794

Trending Articles